Fisetin and quercetin are two flavonoids from everyday plants that are sold together as senolytics, supplements meant to clear the worn-out senescent cells that build up with age. The two are at very different stages.
Fisetin has the more dramatic animal results and the thinner human record: it cleared senescent cells and extended lifespan in aged mice, and its human efficacy trials are still recruiting, so the longevity claim rests on animals.
Quercetin is the one with human data, and that data is modest and specific:
- a few mmHg off blood pressure at higher doses
- some anti-allergic and immune signal
- a trivial edge in endurance
- a long-known problem that it is poorly absorbed
Neither is proven to slow human aging. Here is where each claim actually sits, and the foods that carry both.
Findings & Outcomes
What It Is
Fisetin and quercetin are flavonoids, the colored plant compounds found across fruits and vegetables. Quercetin is the most abundant flavonol in the ordinary diet, richest in capers, onions, apples, berries, and kale. Fisetin is less common and turns up in strawberries, apples, persimmons, and grapes. Both act as antioxidants in the test tube, and both drew fresh attention when laboratory and animal work showed they can behave as senolytics: compounds that clear senescent cells, the worn-out cells that stop dividing but linger in aging tissue and leak inflammatory signals.
Anatomy of the Practice
1In cells and in animals
At the high, intermittent doses used in laboratory research, both flavonoids can push senescent cells toward death. Fisetin carried this furthest in animals, lowering senescence markers across tissues and extending life in aged mice. This is the mechanism the supplements are sold on, and the evidence for it is almost all in cells and animals.
2In the human bloodstream
Getting these compounds into the blood is the bottleneck. Quercetin is poorly and variably absorbed. In people it circulates as modified metabolites, at levels that depend on which food or form it came from, and the free compound barely reaches the blood. Fisetin is thought to share this low bioavailability.
3Over weeks of quercetin
Where quercetin has been given to people for weeks at gram-level doses, the measured shifts are modest and show up mainly in those who had something to move, such as raised blood pressure. In people already in range, there is less to change. The human effects are small and specific.
What It Does
Marketers sell fisetin and quercetin together as a single anti-aging pill. The research puts them at very different stages.
Fisetin sits on the strongest animal result and the thinnest human one. Its lifespan and senolytic findings are in aged mice, where longevity results often fail to carry across to people, and its human trials are under way without an efficacy result yet. Anyone taking fisetin for their own aging is ahead of the human evidence.
Quercetin is the one with a human record, and it is modest and specific. Its findings run from firmest to thinnest:
- Blood pressure: pooled across seven randomized trials in 587 people, about 3 mmHg off, concentrated at 500 mg a day or more.
- Colds: no reduction across a 1002-person trial, though fit adults aged 40 and over taking 1000 mg reported 31 percent fewer sick days.
- Endurance: a very small edge, around 2 percent.
- Allergy and immunity: a signal mostly still at the laboratory stage.
The cards below grade each finding at the strength of its own evidence.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
How it works
Quercetin was one of the first senolytics identified, paired with dasatinib in the research
Quercetin was one of the first compounds found to switch off the survival programs that keep worn-out cells alive.
By mapping the pro-survival networks senescent cells depend on, researchers identified quercetin, alongside dasatinib, as one of the first senolytic compounds, able to block those survival signals so senescent cells undergo the programmed death they had resisted. The selectivity is partial and differs by cell type, and the intermittent research doses are far larger than nutritional supplement doses.
Who this may not transfer to:Mechanism from cell work; research doses far exceed supplement doses.
The study · 1
Zhu 2015, Aging Cell · Aging Cell, 2015
Quercetin is poorly absorbed; no free compound reached the blood in 12 volunteers
Quercetin is absorbed poorly and unevenly; it never showed up in the blood as the free compound, and how much got in depended on the form eaten.
In a four-way crossover of 12 healthy volunteers, no free quercetin appeared in plasma at all, only glucuronide metabolites, and peak levels differed several-fold depending on the sugar form and food matrix, being far higher from onion and quercetin-4-glucoside than from rutin or buckwheat tea. A small pharmacokinetic study measuring blood levels, not a health outcome; it defines the absorption constraint rather than any benefit.
Who this may not transfer to:Small pharmacokinetic study; defines the absorption limit, not a health outcome.
The study · 1
Graefe 2001, Journal of Clinical Pharmacology · J Clin Pharmacol, 2001
Fisetin's health benefits are documented only in cell and animal studies so far
Fisetin's reported health benefits come almost entirely from laboratory and animal work, not from finished human trials.
Reviews of fisetin describe its antioxidant, anti-inflammatory and cytoprotective activity from cell and animal experiments. The compound's documented health effects sit at the preclinical stage, with human efficacy for the outcomes claimed for it not yet established in completed trials. A review summarizes preclinical findings and cannot show a human benefit; it is cited here for the stage of the evidence, not for an effect in people.
Who this may not transfer to:Cell and animal evidence; not yet shown in completed human trials.
The study · 1
Khan 2013, Antioxidants & Redox Signaling · Antioxid Redox Signal, 2013
Heart And Vascular
Quercetin lowered blood pressure about 3 mmHg, mostly at 500 mg a day or more
Across the trials, quercetin took a few points off blood pressure, mostly when the dose was 500 mg a day or higher.
Pooling seven randomized controlled trials in 587 patients, quercetin lowered systolic blood pressure by 3.04 mmHg and diastolic by 2.63 mmHg. The effect was significant in trials using doses of 500 mg a day or more and not significant below that. A small evidence base of seven trials, with the reduction concentrated at higher doses and largely in people whose pressure was already raised.
Who this may not transfer to:Effect largest in people with raised blood pressure and at 500 mg a day or more.
The study · 1
Serban 2016, Journal of the American Heart Association · J Am Heart Assoc, 2016
Respiratory Infection
Quercetin did not cut colds overall; fit adults 40 and over on 1000 mg had 31% fewer sick days
Quercetin did not cut colds across everyone in the trial, though older, fitter people on the higher dose reported fewer and milder sick days.
In a randomized trial of 1002 adults taking 500 or 1000 mg a day of quercetin for twelve weeks, there was no reduction in upper respiratory tract infection rates for the group as a whole. A subgroup of physically fit people aged 40 and over on 1000 mg had 31% fewer sick days and 36% lower symptom severity. The overall result was null; the benefit came from a post-hoc subgroup, which is a lead to test rather than a confirmed effect.
Who this may not transfer to:Null overall; benefit only in a post-hoc subgroup of fit adults 40 and over.
The study · 1
Heinz 2010, Pharmacological Research · Pharmacol Res, 2010
Cardiorespiratory Fitness
Quercetin gave about a 2% edge in endurance, a real but tiny effect
Quercetin gave a real but tiny edge in endurance exercise, on the order of 2%.
A meta-analysis of eleven trials in 254 people, at a median dose of 1000 mg a day, found quercetin produced a statistically significant improvement in endurance capacity and VO2max, but the effect size was between trivial and small, equating to roughly a 2% gain over placebo. The pooled effect is between trivial and small, and study results were mixed, so any practical benefit for a given person is minor.
Who this may not transfer to:Statistically real but between trivial and small for any one person.
The study · 1
Kressler 2011, Medicine & Science in Sports & Exercise · Med Sci Sports Exerc, 2011
Longevity And Mortality
Fisetin extended lifespan in aged mice, the strongest senolytic of the flavonoids tested
Fisetin cleared worn-out cells and lengthened life in aged mice, more strongly than the other plant flavonoids tested.
Screened against a panel of flavonoids, fisetin was the most potent senolytic. In aged mice it reduced senescence markers across several tissues and extended median and maximum lifespan even when started late in life. The doses were high relative to what diet provides, the result is in mice where longevity findings often fail to transfer to people, and a supplement at nutritional doses is not the tested intervention.
Who this may not transfer to:Result is in aged mice; longevity findings often fail to transfer to people.
The study · 1
Yousefzadeh 2018, EBioMedicine · EBioMedicine, 2018
Immune Function
Quercetin calms allergy and inflammation in the lab, with few human trials yet
In the lab quercetin calms the cells that drive allergy and inflammation, though this has mostly not been carried into human trials.
Quercetin stabilizes mast cells and inhibits histamine release, lowers pro-inflammatory cytokines and leukotrienes, and shifts the Th1/Th2 balance, mechanisms relevant to allergic rhinitis and asthma. Most of this evidence is from cell and laboratory models rather than clinical trials. Predominantly mechanistic and in-vitro evidence; controlled human trials in allergic rhinitis are few, so the clinical size of any effect is not established.
Who this may not transfer to:Mostly cell and laboratory models; controlled human allergy trials are few.
The study · 1
Mlcek 2016, Molecules · Molecules, 2016
How It Works
The idea behind both flavonoids as anti-aging supplements is senescence. As tissue ages, some cells stop dividing but do not die, and they secrete a stream of inflammatory signals that irritate the healthy tissue around them. Senolytics are meant to remove those cells selectively. Quercetin was one of the first two compounds identified as a senolytic, found by mapping the survival networks that senescent cells depend on, and it is used in research alongside the prescription drug dasatinib. Fisetin was then singled out as the most potent natural senolytic among a panel of flavonoids tested.
The clinical research on senolytics, including the dasatinib-plus-quercetin combination and the small early human trials, sits on the senolytics page. This page is about the two flavonoids as the supplements people buy, a different question from the drug research. Both run into bioavailability first. Quercetin is absorbed poorly and unevenly, so the large intermittent doses that clear senescent cells in a dish or a mouse are hard to reproduce in a person swallowing capsules. The gap between the research dose and the shelf dose is why the senolytic longevity results and the modest human quercetin findings do not describe the same thing.
The dose on a label is not the dose that reaches a cell.
The wider biology is on the biology of aging, where cellular senescence is one recognized hallmark.
Getting It Right
Ways to Do It
Most of what these two have to offer comes from food, and the food is pleasant to eat. The supplement rungs are for specific targets, and the higher ones belong in a conversation with a clinician.
Quercetin is concentrated in capers, red onions, apples, berries, kale, and green tea; fisetin in strawberries, apples, persimmons, and grapes. A diet with fruit, vegetables, and tea in it supplies both, in the whole-food form the body handles well, and this is the fair first answer for most people who are not chasing a specific number.
The blood-pressure trials that showed an effect used doses of 500 mg a day or more. If lowering blood pressure is your aim, that is the studied range, and it is a decision to make with the clinician who tracks your numbers, since it can stack with blood-pressure medication.
Quercetin is absorbed poorly, so taking it with a meal that has some fat in it is a simple way to help. Some products use forms meant to improve uptake, such as a phytosome or an enzymatically modified version; these cost more and the human outcome data behind them are limited.
The fisetin senolytic and longevity results are in mice, and the human trials have not reported. If you choose to try it, the reasonable footing is that you are running an experiment on yourself with an effect no completed human trial has measured, and that it should not displace the habits with human evidence behind them, such as exercise and sleep.
Supplements are loosely regulated, so a flavonoid carrying an independent testing mark, such as NSF or Informed Choice, is the simplest way to know the capsule holds what the label says. There is no premium form that changes the underlying evidence.
Go Deeper
- Senolytics: the clinical research on clearing senescent cells, including the dasatinib-plus-quercetin combination and the small early human trials, which is the drug side of the story this page approaches as supplements.
- The biology of aging: where cellular senescence sits among the recognized hallmarks of aging, and why the anti-aging compounds as a group are earlier than the marketing suggests.
The Chinese Medicine View
Fisetin and quercetin were isolated by modern chemistry, so they have no place in the classical Chinese pharmacopoeia. There is no channel assigned to either, no temperature or flavor given by any historical text, and reading one back into them would be an invention. What the tradition offers instead is a way of thinking about the foods they come from, laid over the modern compounds as interpretation and held apart from the trial data above.
The richest sources split across two of the tradition's food groups. The berries, apples, persimmons, and grapes that carry fisetin sit among the sweet and sour fruits read as generating fluids and gently nourishing, foods for someone dry or depleted. The onions, capers, and pungent plants richest in quercetin belong to the acrid, warming flavor the tradition associates with moving Qi and dispersing, a different action entirely. That the same class of compound turns up in foods the tradition reads so differently is a caution against treating a flavonoid as a single traditional entity; the classical view is of foods, not of an isolated molecule pulled from them.
Where the two views touch is one idea: the right amount depends on the person. A tradition that treats a cooling, moistening fruit as medicine for someone dry, and a warming, dispersing onion as suited to someone else entirely, would not hand everyone the same daily dose of a concentrated isolate. It would ask who is in front of you. That instinct sits close to a modern reading where quercetin moves blood pressure mainly in the people whose pressure was high to begin with, and does less where there was less to change. The framing is offered as a way of thinking, held apart from any claim about the molecules.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Quercetin up to 1000 mg a day is usually well tolerated, with kidney and drug-interaction cautions
A safety review found that reported adverse effects from supplemental quercetin, commonly sold at up to 1000 mg a day, have been infrequent and mild, but adequate data for high doses beyond twelve weeks are lacking. Animal studies flagged potential to worsen a predamaged kidney and to alter the bioavailability of certain drugs. The kidney and tumor-promotion signals come from animal studies, and long-term high-dose human data are not available, so risk in specific groups is inferred rather than measured.Andres 2018, Molecular Nutrition & Food Research
Quercetin can change how your medications work
Quercetin affects some of the enzymes and transporters that clear other drugs, so it can alter the blood levels of medicines a person already takes. If you are on prescription drugs, have a pharmacist or clinician check for interactions before starting a supplement dose.
High-dose quercetin and the kidneys
A safety review flagged that in animal studies quercetin could worsen damage in an already-injured kidney. If you have kidney disease, reduced kidney function, or take medication that affects the kidneys, raise a quercetin supplement with the clinician who manages that before starting. This is a check-first situation rather than a flat prohibition.
It can lower blood pressure and blood sugar
The measured blood-pressure effect is the reason to be aware of overlap with medication. If you already take drugs for high blood pressure, adding quercetin could stack with them, so tell the clinician who prescribes them and keep an eye on your numbers.
Long-term high-dose safety is not well mapped
Quercetin supplements are commonly sold at up to 1000 mg a day, and reported side effects at those doses have been infrequent and mild. Adequate data on taking high doses for longer than about twelve weeks are limited, so the studied range is the sensible ceiling rather than an established safe limit for years of use.
Senolytic doses are not the supplement doses on the shelf
The senescent-cell clearance seen in research used large, intermittent doses whose benefit and safety in healthy people are not established. Buying fisetin or quercetin at ordinary nutritional doses is not the same intervention, and taking very large doses to copy a trial is not supported by the current evidence.
Pregnancy, breastfeeding and children
Supplemental doses of either flavonoid above what food provides have not been well studied in pregnancy or breastfeeding. Without that evidence, food-level intake is the sensible ceiling in those situations, and a supplement is a conversation to have with a clinician.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does fisetin actually slow aging?
That is not established in people. Fisetin lowered senescent-cell markers and extended lifespan in aged mice, which is a striking animal result, but mouse longevity findings have often failed to carry over to humans. The human trials of fisetin as a senolytic are under way and have not reported an efficacy result. So taking fisetin for your own aging runs ahead of the human evidence, and the longevity claim rests on animals for now.
Does quercetin lower blood pressure?
Modestly, at higher doses. A meta-analysis of seven randomized trials in 587 people found quercetin reduced systolic blood pressure by about 3 mmHg and diastolic by about 2.6 mmHg, with the effect concentrated in trials using 500 mg a day or more. That is a small effect from a fairly small evidence base, and it showed up mainly in people whose pressure was already elevated. Because it overlaps with blood-pressure medication, it is a decision to make with the clinician who tracks your numbers.
Are fisetin and quercetin worth taking as supplements?
It depends on what you want from them, and both run into the same problem: they are poorly absorbed. In a human study no free quercetin reached the blood at all, only modified metabolites, at levels that varied with the form eaten. Quercetin at gram doses has a modest blood-pressure effect and some allergy and immune signal; fisetin's case is still mostly in mice. For general health the foods that carry them are the pleasant, well-absorbed option, and the supplements are for specific goals rather than proven anti-aging.
Is quercetin safe?
For most people at usual supplement doses it is well tolerated, and reported side effects at up to 1000 mg a day have been infrequent and mild. The groups who should check with a clinician first are people with kidney disease, since animal work suggests it may worsen an already-damaged kidney, and anyone on blood-pressure medication or other prescription drugs it could interact with. Data on high doses taken for longer than about twelve weeks are limited, so the studied range is the sensible ceiling.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 9 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.